Holen Sie sich die Stockscreener-App
430.14
0.97%
4.13
Vorhandelsmarkt:
427.00
-3.14
-0.73%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt VRTX?
Forum
Prognose
Aktiensplit
Vertex Pharmaceuticals Inc Aktie (VRTX) Neueste Nachrichten
Vertex Pharmaceuticals (NASDAQ:VRTX): Strong Growth Stock with Promising Technical Setup - ChartMill
Vertex Gears Up to Report Q1 Earnings: What Investors Can Expect - Yahoo Finance
Vertex Pharma stock (US92532F1003): Is cystic fibrosis dominance still enough for long-term upside? - AD HOC NEWS
A Look At Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Weakness - Yahoo Finance
Is Vertex Pharmaceuticals heading to $600? - MSN
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Vertex Pharmaceuticals Incorporated (VRTX) is attracting investor attention: Here is what you should know - MSN
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Vanguard Group Inc. - MarketBeat
Vertex Pharma in pact with Halozyme for Hypercon drug delivery tech - MSN
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch
Vertex Pharmaceuticals Incorporated (VRTX) PT Nudged Higher as RBC Updates Biotech Sector Outlook - Yahoo Finance
Vertex Pharmaceuticals Incorporated $VRTX Shares Purchased by M&T Bank Corp - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Purchased by China Universal Asset Management Co. Ltd. - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Arizona State Retirement System - MarketBeat
Layoff Tracker: Tempero winding down following serious adverse event - BioSpace
Teacher Retirement System of Texas Decreases Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Evergreen Capital Management LLC Buys 2,304 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
3 Healthcare Stocks With the Most Durable Competitive Moats - The Motley Fool
B. Metzler seel. Sohn & Co. AG Buys 199,847 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Inc. (VRTX)Bullish Jim Cramer Endorsement Highlights Divergent Sentiment Amid Mixed Pipeline UpdatesAsset Sale - Xã Thanh Hà
Best Biotech Stocks To Watch TodayApril 22nd - MarketBeat
Bernstein Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $577 - Moomoo
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Vertex Pharmaceuticals: Looking For Signs Of Success In Q1 Earnings (NASDAQ:VRTX) - Seeking Alpha
Vertex Pharmaceuticals Incorporated $VRTX Shares Acquired by Caprock Group LLC - MarketBeat
VRTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Jim Cramer on Vertex Pharmaceuticals: “I Wish I Had Bought It for the Charitable Trust a Long Time Ago” - Insider Monkey
Morgan Stanley Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $612 - Moomoo
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
SageGuard Financial Group LLC Makes New $3.67 Million Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Jones Kertz & Associates Inc. Invests $1.82 Million in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Halozyme Therapeutics Partners with Vertex for Hypercon Technology - HarianBasis.co
Fierce Biotech Layoff Tracker 2026: Replimune reduces staff; Astellas shutters cell therapy site - Fierce Biotech
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Vertex Pharma stock (US92532F1003): Is the cystic fibrosis dominance now unlocking broader upside? - AD HOC NEWS
Vertex Pharma stock (US92532F1003): Is its cystic fibrosis dominance strong enough to unlock new ups - AD HOC NEWS
Zurcher Kantonalbank Zurich Cantonalbank Has $160.26 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Merit Financial Group LLC Buys 2,880 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term - The Motley Fool
Vertex Pharmaceuticals Experiences Evaluation Revision Amid Mixed Market Performance Indicators - Markets Mojo
GF Fund Management CO. LTD. Raises Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Stock Position Lifted by Asset Management One Co. Ltd. - MarketBeat
Morgan Stanley Lifts Vertex Pharmaceuticals (VRTX) PT on Updated Biopharma Models - Insider Monkey
Cramer's lightning round: Buy Vertex Pharmaceuticals - MSN
Lightning round: Buy Vertex Pharmaceuticals - MSN
Lightning Round: Buy Vertex Pharmaceuticals - CNBC
Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Vertex (VRTX) director receives new deferred stock unit grant - Stock Titan
VRTX Stock Quote Price and Forecast - CNN
Vertex (NASDAQ: VRTX) director granted 107 deferred stock units as equity pay - Stock Titan
Vertex (VRTX) board member receives deferred stock unit award - Stock Titan
Vertex Pharmaceuticals Incorporated $VRTX Shares Acquired by Mirae Asset Global Investments Co. Ltd. - MarketBeat
KBC Group NV Acquires 7,518 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
Vertex’s IgAN drug outlook strengthens on positive phase 3 data - S&P Global
Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Is Vertex Pharmaceuticals' Empire in Trouble? - AOL.com
Vertex Pharmaceuticals Incorporated : 2025 Data Summary - marketscreener.com
Vertex price returns lowerForecast today16-04-2026 - Economies.com
Morgan Stanley Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX) - The Globe and Mail
Lbp Am Sa Acquires 22,918 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Inc (STU:VX1) Stock Price & 30 Year Financial Data - GuruFocus
1.70%
9.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):